Works matching IS 02683369 AND DT 2015 AND VI 50 AND IP 4

Results: 29

Efficiency of allogeneic hematopoietic SCT from HLA fully-matched non-sibling relatives: A new prospect of exploiting extended family search.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 545, doi. 10.1038/bmt.2014.307

By:

Hamidieh, A A;
Dehaghi, M Ostadali;
Paragomi, P;
Navaei, S;
Jalali, A;
Eslami, G Ghazizadeh;
Behfar, M;
Ghavamzadeh, A

Publication type:

Article

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 476, doi. 10.1038/bmt.2014.312

By:

Passweg, J R;
Baldomero, H;
Bader, P;
Bonini, C;
Cesaro, S;
Dreger, P;
Duarte, R F;
Dufour, C;
Falkenburg, J H F;
Farge-Bancel, D;
Gennery, A;
Kröger, N;
Lanza, F;
Nagler, A;
Sureda, A;
Mohty, M

Publication type:

Article

I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 607, doi. 10.1038/bmt.2014.316

By:

Yamamoto, H;
Uchida, N;
Matsuno, N;
Kon, A;
Nishida, A;
Ota, H;
Ikebe, T;
Nakano, N;
Ishiwata, K;
Araoka, H;
Takagi, S;
Tsuji, M;
Asano-Mori, Y;
Yamamoto, G;
Izutsu, K;
Masuoka, K;
Wake, A;
Yoneyama, A;
Makino, S;
Taniguchi, S

Publication type:

Article

High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 499, doi. 10.1038/bmt.2014.304

By:

Castagna, L;
Crocchiolo, R;
Giordano, L;
Bramanti, S;
Carlo-Stella, C;
Sarina, B;
Chiti, A;
Mauro, E;
Gandolfi, S;
Todisco, E;
Balzarotti, M;
Anastasia, A;
Magagnoli, M;
Brusamolino, E;
Santoro, A

Publication type:

Article

Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 553, doi. 10.1038/bmt.2014.315

By:

Takano, K;
Fuji, S;
Uchida, N;
Ogawa, H;
Ohashi, K;
Eto, T;
Sakamaki, H;
Morishima, Y;
Kato, K;
Suzuki, R;
Fukuda, T

Publication type:

Article

Cord blood collection and banking from a population with highly diverse geographic origins increase HLA diversity in the registry and do not lower the proportion of validated cord blood units: experience of the Marseille cord blood bank.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 531, doi. 10.1038/bmt.2014.314

By:

Bordoni, C;
Magalon, J;
Gilbertas, C;
Gamerre, M;
Le Coz, P;
Berthomieu, M;
Chabannon, C;
Di Cristofaro, J;
Picard, C

Publication type:

Article

Engraftment syndrome, the Emperor's new clothes and the artist formerly known as prince.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 483, doi. 10.1038/bmt.2014.317

By:

Gale, R P;
Lazarus, H M

Publication type:

Article

Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 579, doi. 10.1038/bmt.2014.298

By:

García-Cadenas, I;
Castillo, N;
Martino, R;
Barba, P;
Esquirol, A;
Novelli, S;
Orti, G;
Garrido, A;
Saavedra, S;
Moreno, C;
Granell, M;
Briones, J;
Brunet, S;
Navarro, F;
Ruiz, I;
Rabella, N;
Valcárcel, D;
Sierra, J

Publication type:

Article

Characteristic patterns of relapse after allogeneic hematopoietic SCT for adult T-cell leukemia-lymphoma: a comparative study of recurrent lesions after transplantation and chemotherapy by the Nagasaki Transplant Group.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 585, doi. 10.1038/bmt.2014.308

By:

Itonaga, H;
Sawayama, Y;
Taguchi, J;
Honda, S;
Taniguchi, H;
Makiyama, J;
Matsuo, E;
Sato, S;
Ando, K;
Imanishi, D;
Imaizumi, Y;
Yoshida, S;
Hata, T;
Moriuchi, Y;
Fukushima, T;
Miyazaki, Y

Publication type:

Article

Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 566, doi. 10.1038/bmt.2014.313

By:

Lim, A B M;
Storek, J;
Beligaswatte, A;
Collins, M;
Tacey, M;
Williamson, T;
Mason, K;
Li, E;
Chaudhry, M A;
Russell, J A;
Daly, A;
Szer, J;
Lewis, I;
Ritchie, D

Publication type:

Article

Major ABO incompatible BMT in children: determining what residual volume of donor red cells can safely be infused following red cell depletion.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 536, doi. 10.1038/bmt.2014.309

By:

Patrick, K;
Lau, W;
Gassas, A;
McDougall, E;
Doyle, J;
Ali, M;
Krueger, J;
Courtney, S;
Armstrong, C;
Egeler, R M;
Schechter, T

Publication type:

Article

Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myeloma.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 511, doi. 10.1038/bmt.2014.319

By:

Giaccone, L;
Brunello, L;
Festuccia, M;
Gilestro, M;
Maffini, E;
Ferrando, F;
Talamo, E;
Passera, R;
Boccadoro, M;
Omedè, P;
Bruno, B

Publication type:

Article

Ponatinib given for advanced leukemia relapse after allo-SCT.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 599, doi. 10.1038/bmt.2014.301

By:

Hirschbuehl, K;
Rank, A;
Pfeiffer, T;
Slawik, H R;
Schlimok, G;
Kolb, H J;
Schmid, Ch

Publication type:

Article

Treatment of donor-specific antibody-mediated graft rejection by immunochemotherapy, third-party DLI, plasmapheresis and immunoadsorption.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 613, doi. 10.1038/bmt.2014.321

By:

Wilk, C M;
Fischer, J C;
Schieren, G;
Rox, J M;
Haas, R;
Rump, L C;
Kobbe, G;
Schroeder, T

Publication type:

Article

Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 592, doi. 10.1038/bmt.2014.306

By:

Lawitschka, A;
Faraci, M;
Yaniv, I;
Veys, P;
Bader, P;
Wachowiak, J;
Socie, G;
Aljurf, M D;
Arat, M;
Boelens, J J;
Duarte, R;
Tichelli, A;
Peters, C

Publication type:

Article

Inadvertent transmission of occult CML through allo-SCT.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 598, doi. 10.1038/bmt.2014.294

By:

de Brito, M D;
Campilho, F;
Branca, R;
Vaz, C P;
Campos, A

Publication type:

Article

Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 559, doi. 10.1038/bmt.2014.293

By:

Nakasone, H;
Fukuda, T;
Kanda, J;
Mori, T;
Yano, S;
Kobayashi, T;
Miyamura, K;
Eto, T;
Kanamori, H;
Iwato, K;
Uchida, N;
Mori, S;
Nagamura-Inoue, T;
Ichinohe, T;
Atsuta, Y;
Teshima, T;
Murata, M

Publication type:

Article

Engraftment syndrome: double-edged sword of hematopoietic cell transplants.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 469, doi. 10.1038/bmt.2014.296

By:

Spitzer, T R

Publication type:

Article

A retrospective comparison of BU-fludarabine and BU-CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 601, doi. 10.1038/bmt.2014.303

By:

Sun, Y-q;
Xu, L-p;
Zhang, X-h;
Liu, D-h;
Chen, H;
Wang, Y;
Yan, C-h;
Wang, J-z;
Wang, F-r;
Zhang, Y-y;
Liu, K-y;
Huang, X-j

Publication type:

Article

Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 485, doi. 10.1038/bmt.2014.300

By:

Sauer, T;
Silling, G;
Groth, C;
Rosenow, F;
Krug, U;
Görlich, D;
Evers, G;
Albring, J;
Besoke, R;
Mesters, R M;
Müller-Tidow, C;
Kessler, T;
Büchner, T;
Berdel, W E;
Stelljes, M

Publication type:

Article

Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 540, doi. 10.1038/bmt.2014.305

By:

Kosmoliaptsis, V;
Jöris, M M;
Mallon, D H;
Lankester, A C;
von dem Borne, P A;
Kuball, J;
Bierings, M;
Cornelissen, J J;
Groenendijk-Sijnke, M E;
van der Holt, B;
Bradley, J A;
Oudshoorn, M;
van Rood, J J;
Taylor, C J;
Claas, F H J

Publication type:

Article

Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 505, doi. 10.1038/bmt.2014.310

By:

Iacobelli, S;
de Wreede, L C;
Schönland, S;
Björkstrand, B;
Hegenbart, U;
Gruber, A;
Greinix, H;
Volin, L;
Narni, F;
Carella, A M;
Beksac, M;
Bosi, A;
Milone, G;
Corradini, P;
Friberg, K;
van Biezen, A;
Goldschmidt, H;
de Witte, T;
Morris, C;
Niederwieser, D

Publication type:

Article

Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 573, doi. 10.1038/bmt.2014.290

By:

Kamber, C;
Zimmerli, S;
Suter-Riniker, F;
Mueller, B U;
Taleghani, B M;
Betticher, D;
Zander, T;
Pabst, T

Publication type:

Article

Pegfilgrastim vs filgrastim in PBSC mobilization for autologous hematopoietic SCT: a systematic review and meta-analysis.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 523, doi. 10.1038/bmt.2014.297

By:

Kim, M G;
Han, N;
Lee, E-K;
Kim, T

Publication type:

Article

Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 610, doi. 10.1038/bmt.2014.318

By:

Dhakal, B;
D'Souza, A;
Arce-Lara, C;
Pasquini, M;
Saber, W;
Falvo, F;
Esselman, J;
Zellner, K;
Fenske, T;
Hari, P N;
Hamadani, M

Publication type:

Article

Hematopoietic SCT in Iranian children 1991-2012.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 517, doi. 10.1038/bmt.2014.299

By:

Hamidieh, A A;
Behfar, M;
Babaki, A E S;
Jalali, A;
Hosseini, A-S;
Jahani, M;
Alimoghaddam, K;
Ghavamzadeh, A

Publication type:

Article

Important impact of gingival and periodontal conditions on outcomes in SCT recipients.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 604, doi. 10.1038/bmt.2014.311

By:

Allareddy, V;
Venugopalan, S R;
Eswaran, S V K;
Rampa, S;
Anamali, S;
Nalliah, R P;
Shin, K;
Elangovan, S

Publication type:

Article

Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 493, doi. 10.1038/bmt.2014.302

By:

Hobbs, G S;
Hamdi, A;
Hilden, P D;
Goldberg, J D;
Poon, M L;
Ledesma, C;
Devlin, S M;
Rondon, G;
Papadopoulos, E B;
Jakubowski, A A;
O'Reilly, R J;
Champlin, R E;
Giralt, S;
Perales, M-A;
Kebriaei, P

Publication type:

Article

Constituting a public umbilical cord blood bank in South Africa.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 615, doi. 10.1038/bmt.2014.329

By:

Mellet, J;
Alessandrini, M;
Steel, H C;
Pepper, M S

Publication type:

Article